Home LiteratureArticle Details
PMID: 22555458 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

miR-205 regulates basement membrane deposition in human prostate: implications for cancer development.

Cell death and differentiation ·Vol. 19 ·No. 11 ·2012-11-00 ·Pages 1750-60

Gandellini P, Profumo V, Casamichele A, Fenderico N, Borrelli S, Petrovich G, Santilli G, Callari M, Colecchia M, Pozzi S, De Cesare M, Folini M, Valdagni R, Mantovani R, Zaffaroni N

Abstract

The basement membrane (BM) is a layer of specialized extracellular matrix that surrounds normal prostate glands and preserves tissue integrity. Lack or discontinuity of the BM is a prerequisite for tumor cell invasion into interstitial spaces, thus favoring metastasis. Therefore, BM maintenance represents a barrier against cancer development and progression. In the study, we show that miR-205 participates in a network involving ΔNp63α, which is essential for maintenance of the BM in prostate epithelium. At the molecular level, ΔNp63α is able to enhance miR-205 transcription by binding to its promoter, whereas the microRNA can post-transcriptionally limit the amount of ΔNp63α protein, mostly by affecting ΔNp63α proteasomal degradation rather than through a canonical miRNA/target interaction. Functionally, miR-205 is able to control the deposition of laminin-332 and its receptor integrin-β4. Hence, pathological loss of miR-205, as widely observed in prostate cancer, may favor tumorigenesis by creating discontinuities in the BM. Here we demonstrate that therapeutic replacement of miR-205 in prostate cancer (PCa) cells can restore BM deposition and 3D organization into normal-like acinar structures, thus hampering cancer progression.

MeSH Terms
Basement Membrane/metabolism Cell Adhesion Molecules/metabolism Cell Line Cell Transformation, Neoplastic Humans Integrin beta4/metabolism Male MicroRNAs/genetics,metabolism Promoter Regions, Genetic Prostate/metabolism Transcription Factors/metabolism Transcription, Genetic Tumor Suppressor Proteins/metabolism
Chemicals
Cell Adhesion Molecules Integrin beta4 MIRN205 microRNA, human MicroRNAs TP63 protein, human Transcription Factors Tumor Suppressor Proteins kalinin
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Gandellini P
Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Profumo V
Casamichele A
Fenderico N
Borrelli S
Petrovich G
Santilli G
Callari M
Colecchia M
Pozzi S
De Cesare M
Folini M
Valdagni R
Mantovani R
Zaffaroni N
References (39)
39 references, click to expand
  1. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.
    Cancer Res. 2008 Aug 1;68(15):6162-70 PMID: 18676839
  2. Basal epithelial stem cells are efficient targets for prostate cancer initiation.
    Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2610-5 PMID: 20133806
  3. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
    Cancer Res. 2007 Dec 15;67(24):11612-20 PMID: 18089790
  4. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors.
    Nat Rev Urol. 2010 May;7(5):286-97 PMID: 20368743
  5. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.
    Gastroenterology. 2006 Sep;131(3):830-40 PMID: 16952552
  6. MicroRNA-205 promotes keratinocyte migration via the lipid phosphatase SHIP2.
    FASEB J. 2010 Oct;24(10):3950-9 PMID: 20530248
  7. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer.
    Oncogene. 2011 Mar 3;30(9):1098-107 PMID: 21042282
  8. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.
    Carcinogenesis. 1997 Jun;18(6):1215-23 PMID: 9214605
  9. Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells.
    Cell Death Dis. 2010 Dec 09;1:e105 PMID: 21368878
  10. p51/p63 Controls subunit alpha3 of the major epidermis integrin anchoring the stem cells to the niche.
    J Biol Chem. 2004 Nov 26;279(48):50069-77 PMID: 15361520
  11. Culture requirements of prostatic epithelial cell lines for acinar morphogenesis and lumen formation in vitro: role of extracellular calcium.
    Prostate. 2007 Nov 1;67(15):1601-13 PMID: 17705248
  12. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Int J Cancer. 2010 Mar 1;126(5):1166-76 PMID: 19676045
  13. Correlated alterations in prostate basal cell layer and basement membrane.
    Int J Biol Sci. 2009;5(3):276-85 PMID: 19343113
  14. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    J Clin Oncol. 2009 Apr 20;27(12):2030-7 PMID: 19273703
  15. ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cells.
    J Biol Chem. 2010 Oct 29;285(44):33940-8 PMID: 20729552
  16. deltaEF1 repressor controls selectively p53 family members during differentiation.
    Oncogene. 2005 Nov 10;24(49):7273-80 PMID: 16007124
  17. Analysis of regulatory network topology reveals functionally distinct classes of microRNAs.
    Nucleic Acids Res. 2008 Nov;36(20):6494-503 PMID: 18927108
  18. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53.
    FEBS Lett. 2006 Aug 7;580(18):4544-50 PMID: 16870177
  19. Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63.
    Oncotarget. 2012 Feb;3(2):132-43 PMID: 22361592
  20. Low-density Taqman miRNA array reveals miRNAs differentially expressed in prostatic stem cells and luminal cells.
    Prostate. 2010 Feb 15;70(3):297-304 PMID: 19827049
  21. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.
    J Natl Cancer Inst. 2002 Oct 2;94(19):1494-503 PMID: 12359858
  22. Towards the definition of prostate cancer-related microRNAs: where are we now?
    Trends Mol Med. 2009 Sep;15(9):381-90 PMID: 19716766
  23. p63 induces key target genes required for epidermal morphogenesis.
    Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3255-60 PMID: 17360634
  24. Chromatin immunoprecipitation (ChIP) on chip experiments uncover a widespread distribution of NF-Y binding CCAAT sites outside of core promoters.
    J Biol Chem. 2005 Apr 8;280(14):13606-15 PMID: 15647281
  25. MicroRNAs as new therapeutic targets and tools in cancer.
    Expert Opin Ther Targets. 2011 Mar;15(3):265-79 PMID: 21208133
  26. Structure and function of basement membranes.
    Exp Biol Med (Maywood). 2007 Oct;232(9):1121-9 PMID: 17895520
  27. p63 regulates commitment to the prostate cell lineage.
    Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11355-60 PMID: 16051706
  28. The role of the ZEB family of transcription factors in development and disease.
    Cell Mol Life Sci. 2009 Mar;66(5):773-87 PMID: 19011757
  29. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
    Cancer Res. 2009 Mar 15;69(6):2287-95 PMID: 19244118
  30. MicroRNAs: target recognition and regulatory functions.
    Cell. 2009 Jan 23;136(2):215-33 PMID: 19167326
  31. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.
    PLoS One. 2010 May 03;5(5):e10431 PMID: 20454659
  32. p63 in prostate biology and pathology.
    J Cell Biochem. 2008 Apr 1;103(5):1354-68 PMID: 17879953
  33. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Nat Cell Biol. 2008 May;10(5):593-601 PMID: 18376396
  34. p63 regulates an adhesion programme and cell survival in epithelial cells.
    Nat Cell Biol. 2006 Jun;8(6):551-61 PMID: 16715076
  35. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
    PLoS One. 2009;4(3):e4687 PMID: 19262738
  36. Stem cells in prostate cancer: treating the root of the problem.
    Endocr Relat Cancer. 2010 Sep 23;17(4):R273-85 PMID: 20660571
  37. Defining the role of laminin-332 in carcinoma.
    Matrix Biol. 2009 Oct;28(8):445-55 PMID: 19686849
  38. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Mod Pathol. 2002 Dec;15(12):1302-8 PMID: 12481011
  39. Defining cell lineages in the prostate epithelium.
    Cell Cycle. 2006 Jan;5(2):138-41 PMID: 16357539
Article Info
Journal
Cell death and differentiation
Abbr.
Cell Death Differ
ISSN
1476-5403
Published
2012-11-00
Epub
2012-00-04
Pages
1750-60
Language
English
Region
England
NLM ID
9437445
PMCID
PMC3469086
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]